<DOC>
	<DOCNO>NCT00496171</DOCNO>
	<brief_summary>The purpose study determine effective formulation HAL release hexaminolevulinate cervical epithelium different dos .</brief_summary>
	<brief_title>Phase I Study HAL Formulations Applied Cervix Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy , premenopausal female volunteer Acute chronic disease could influence study result</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>